UC Davis Health to enroll participants for major COVID-19 vaccine clinical trial
Sacramento’s academic medical center is one of only 120 sites chosen for global study that could lead to much-needed vaccine by year’s end
(SACRAMENTO) —
UC Davis Health today announced a partnership with Pfizer Inc. and BioNTech SE to participate in a global study of an investigational vaccine against COVID-19, adding a significant component to the university’s response to the deadly coronavirus pandemic.
Read more...